[Skip to Content]
[Skip to Content Landing]
November 1979

The Use of Thymoxamine in Eyelid Retraction

Author Affiliations

From the Oculoplastic Service, Department of Ophthalmology, University of Iowa, Iowa City. Dr Dixon is now with the Oculoplastic Service, Department of Ophthalmology, Henry Ford Hospital, Detroit. Dr Hatt is now with the University Eye Clinic, Kantonsspital, Zurich, Switzerland.

Arch Ophthalmol. 1979;97(11):2147-2150. doi:10.1001/archopht.1979.01020020465012

• We observed substantial narrowing in 75% of fissures in patients with various types of lid retraction after topical application of aqueous 0.5% thymoxamine (moxisylyte). Even contralateral normal-appearing fissures in thyroid patients responded in this manner. The nonresponders in the lid retraction group included a patient with an orbital pseudotumor and patients with long-standing and stable euthyroid eye disease. No normal subjects' fissures responded greatly to thymoxamine. A substantial reduction in palpebral fissures was seen in all patients with thick extraocular muscles and in 14 of 18 (78%) of all fissures of thyroid patients; the average response was 2.3 mm. This effect may last for five hours after thymoxamine administration. Thymoxamine may be of use as a diagnostic test for thyroid eye disease, and if it can be modified to cause less ocular irritation, it may be beneficial in the medical treatment of eyelid retraction.